Navigation Links
Dendreon Reports Fourth Quarter and 2008 Year End Financial Results
Date:3/12/2009

bout the Company and its programs, visit www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties surrounding the efficacy of PROVENGE to treat men suffering from prostate cancer, risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Factors that may cause such differences include risks related to our limited operating history, risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of existing clinical trials or from additional clinical trials for PROVENGE will not support approval for a biologics license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the FDA will not approve a product for which a biologics license has been applied, the risk that the results of a clinical trial for PROVENGE or other product may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital to fund required clinical trials or commercialization of PROVENGE, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov.

                               DENDREON CORPORATION
                
'/>"/>
SOURCE  Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. Dendreon Reports Third Quarter 2007 Financial Results
6. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
9. -Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
10. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
11. Dendreon Reports Fourth Quarter and 2007 Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 18, 2013 A new look ... costs and other trends will highlight technical sessions at ... this fall. In its 33rd year, the three-day event ... exhibition of key suppliers, approximately 100 technical presentations and ... the international society for optics and photonics , the ...
(Date:6/19/2013)... 2013 Adding to their already extensive ... with Simport’s Dropette® and Heathrow Scientific disposable plastic ... doing basic biology, chemistry and any type of liquid ... over 35 years, Simport has been supplying the science ... like the Simport Dropette®. Simport’s Dropette® is a one-piece ...
(Date:6/18/2013)... 2013) A million electric cars could be on roads ... the help of research by the United States Department of ... , Professor Zhongwei Chen is part of a team led ... materials to replace the expensive platinum catalysts in fuel cells. ... fuel cells in vehicles is the cost of the units. ...
(Date:6/18/2013)... New York, NY (PRWEB) June 18, 2013 ... technological innovation and sustainability, the Consulate General of Switzerland ... largest solar boat, Switzerland’s MS Tûranor PlanetSolar , ... as part of its DeepWater Expedition 2013 tour with ... catamaran, led by Capitain Gérard d’Aboville, runs exclusively on ...
Breaking Biology Technology:‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2US and Canadian researchers drive towards cheaper fuel cells for electric cars 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4
... The results of two new large scale,trials show ... only is effective against uncomplicated malaria in a ... (ACTs), but it,also protects patients against new infections ... combination is very well tolerated with no significant,side ...
... Despite difficult,financial times and flat federal funding of biomedical ... and at modest cost --,can yield dramatic results for ... National Cancer Institute (NCI) in a commentary published today ... http://www.newscom.com/cgi-bin/prnh/20080627/CLF051LOGO ) , In ...
... Jan. 15 Sullivan, Cotter and Associates, Inc.,(SullivanCotter) ... Survey Report, the industry standard. Notable findings ... for specialists and 4.0% for,primary care physicians. ... increases to their employed physicians in 2008,which is ...
Cached Biology Technology:Malaria: New Treatment is Upcoming 2Malaria: New Treatment is Upcoming 3National Cancer Institute: Battling Cancer and a Recession 2National Cancer Institute: Battling Cancer and a Recession 3Despite Economic Woes, Physician Compensation Increases 2Despite Economic Woes, Physician Compensation Increases 3
(Date:6/18/2013)... a very large "dead zone" in the Gulf of ... the Chesapeake Bay this year, based on several NOAA-supported ... Michigan, Louisiana State University, and the Louisiana Universities ... Mexico hypoxic "dead" zone will be between 7,286 and ... ten largest recorded. That would range from an area ...
(Date:6/18/2013)... June 18, 2013 Joshua Obar, Ph.D., Department ... been honored with a 2013 ICAAC Young Investigator Award ... of immunological memory responses to infection. , Obar ... in 2001 and went on to complete his Ph.D. ... He performed his Ph.D. thesis research in Edward ...
(Date:6/18/2013)... is estimated that between 5% and 10% of breast ... to say that these tumours are attributable to inherited ... or BRCA2. In patients with these mutations, PARP inhibitors, ... results that make them a new option for personalised ... latest studies indicate that a fraction of these patients ...
Breaking Biology News(10 mins):NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4The American Society for Microbiology honors Joshua Obar 2An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2
... PROVIDENCE, R.I. [Brown University] Excessive weight gain isn,t ... it can do lasting harm to the mother and ... Miriam Hospital are encouraged by a new study describing ... "This study suggests that a lifestyle intervention can ...
... Feb. 28, 2011 Science fiction novelist and scholar Issac ... science, the one that heralds new discoveries, is not ,Eureka!, ... an international team of researchers when they observed something they ... Chemistry "Paper of the Week," the Berlin-based team reports ...
... North America have been awarded Leopold Leadership Fellowships ... Woods Institute for the Environment, the Leopold Leadership ... scientists make their knowledge accessible to decision makers. ... 20 mid-career academic environmental researchers as fellows. They ...
Cached Biology News:Intervention helps women manage weight during and after pregnancy 2Intervention helps women manage weight during and after pregnancy 3Intervention helps women manage weight during and after pregnancy 4Researchers develop curious snapshot of powerful retinal pigment and its partners 2Researchers develop curious snapshot of powerful retinal pigment and its partners 320 researchers selected as 2011 Leopold Leadership Fellows 220 researchers selected as 2011 Leopold Leadership Fellows 320 researchers selected as 2011 Leopold Leadership Fellows 4
...
... At the forefront of Agilent analytical solutions ... local area networking (LAN) allows you to ... fast and informed decision making. Just as ... all the flexibility and performance needed for ...
... Solomon's laboratory animal infusion kits reduce the ... infusion study while providing sterile equipment to ... includes everything you need for one animal, ... and tethers will be cut to the ...
... The PolarScreen Peroxisome Proliferator-Activated Receptor-gamma ... a sensitive and efficient method ... PPARGamma ligands using fluorescence polarization ... PPARGamma-Ligand binding domain (PPARGamma-LBD) with ...
Biology Products: